tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
PremiumThe FlyClosing Bell Movers: Victory Capital gains on S&P 400 inclusion
1M ago
Repare Therapeutics enters licensing pact with Debiopharm for Lunresertib
Premium
The Fly
Repare Therapeutics enters licensing pact with Debiopharm for Lunresertib
1M ago
Repare Therapeutics Updates Severance Benefits for Executives
Premium
Company Announcements
Repare Therapeutics Updates Severance Benefits for Executives
2M ago
Repare Therapeutics expects cash to fund operations through 2027
PremiumThe FlyRepare Therapeutics expects cash to fund operations through 2027
3M ago
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RPTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
Premium
Company Announcements
Repare Therapeutics Out-Licenses Platforms to DCx Biotherapeutics
4M ago
Repare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
PremiumRatingsRepare Therapeutics: Strategic Focus and Financial Stability Underpin Buy Rating
5M ago
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
Premium
Ratings
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics
6M ago
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
Premium
The Fly
Repare Therapeutics price target lowered to $5 from $10 at H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100